University of Applied Sciences Utrecht Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2011
NCT01232257
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

A.C. Abrahams | University of Applied Sciences Utrecht

Active Ingredients

Drugs in Phase 3 Trials (1)

acetylcysteine (mucomyst) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 3)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1